Ocimum Biosolutions Ltd. Company Profile
Ocimum Biosolutions is a life sciences R&D enabling company with three focus areas, BioIT, Microarrays and Research services. The Microarray division of Ocimum has been recently acquired from MWG Biotech. These include Catalog “OciChip”, Custom “OciChip” and microarray services.
The BioIT division of Ocimum Biosolutions provides key, ready to use reliable, cost-effective software solutions for the biotech/pharma industry with a suite of products such as Biotracker™, Toxchek™, Pharmatracker™, Genchek™, OptGene™, Nutrabase™, Genowiz™ and iRNAchek™, and an array of custom services including Data mining, Algorithm development, Gene identification, Multiple-platform software development, Database creation and manipulation, and tools for image analysis.
The Research services division provides molecular biology services like GMO testing, Nucleic Acid Purification, DNA extractions, Oligonucleotide synthesis and Gene synthesis
Location
6th Floor, Reliance ClassicRoad No. 1, Banjara Hills
Hyderabad
Andhra Pradesh
500 034
India
Contact
Phone: 91-40-6662-7200
Fax: 91-40-6662-7205
Email: hyd@ocimumbio.com
News Articles
Emergent BioSolutions: Company profile
Return to bigbiotech list Summary Website: Emergent BioSolutions Headquarters: Maryland , USA SEC Link: Emergent Biosolutions Subsidiary Companies: BioPort Emergent Product Development Epic Bio Micro...
Emergent BioSolutions to Present at Cowen and Company 33rd Annual Health Care Conference
Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will provide a corporate overview presentation at the Cowen and Comp...
Emergent BioSolutions secures funding from BARDA for anthrax vaccine
Emergent BioSolutions of Rockville, Md., has reached an agreement with the Biomedical Advanced Research and Development Authority (BARDA) to conduct a non-interference study to be used to support a po...
Emergent BioSolutions provides update on TRU-016 Phase 1b study
Emergent BioSolutions Inc. today announced its decision to expand the protocol for its ongoing Phase 1b, single arm, open label study (Protocol 16009) evaluating the safety and efficacy of TRU-016 in...
Emergent BioSolutions to Participate in Piper Jaffray’s 24th Annual Healthcare Conference
Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will lead a discussion, which may involve recent business dev...
Emergent BioSolutions Inc. (NYSE: EBS) has announced that it will hold its Annual Meeting of Stockholders on Thursday, May 23, 2013 beginning at 9:00 AM Eastern at the Sheraton Ro...
Emergent BioSolutions commences NuThrax Phase 2 trial in anthrax infection
Emergent BioSolutions Inc. today announced the initiation of a Phase 2 clinical trial for NuThrax (Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant), also known as AV7909, with the dosing of the first...
Emergent BioSolutions to Present at ThinkEquity’s 9th Annual Growth Conference
Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the ThinkEquity 9th Annual Growth Conference in New York on Wednesda...
Drugs and Medications
Artemis alcohol-free antiseptic foam hand [Artemis Bio-Solutions Inc]
ARTEMIS ALCOHOL-FREE Antiseptic Foam Hand Soap
Artemis alcohol-free antiseptic foam hand sanitizer [Artemis Bio-Solutions Inc]
ARTEMIS ALCOHOL-FREE Antiseptic Foam Hand Sanitizer
Frais hand sanitizer [Frais Luxury Products]
Frais Hand Sanitizer
Jasmine tea and basil antibacterial hand sanitizer [HEB]
DRUG FACTS
Jasmine tea and basil antibacterial hand sanitizer [HEB]
DRUG FACTS
PubMed Articles
Ethnopharmacological relevance: Ocimum basilicum belongs to the genus Ocimum (Lamiaceae). Many species of this genus including O. basilicum have been traditionally used for the treatment of a variety...
In vivo anti-inflammatory activities of Ocimum suave in mice.
Ocimum suave has been used in the Ethiopian traditional medicine to relieve pain, fever, inflammation and other disease conditions.
Rapid synthesis of silver nanoparticles using dried medicinal plant of basil.
Plants respond to heavy metal stress by metal complexation process like production of phytochelations or by other metal chelating peptides. In this paper we report the synthesis of silver nanoparticle...
The antioxidant effects of Ocimum sanctum in experimental streptozocin-induced diabetic rats was evaluated in this study. Streptozocin, 55 mg kg(-1) body weight, was injected intraperitoneally onc...
The leaf extract of Ocimum sanctum was used as a reducing agent for the synthesis of platinum nanoparticles from an aqueous chloroplatinic acid (H(2)PtCl(6)·6H(2)O). A greater conversion of platinum...
Clinical Trials
None
Companies
Ocimum Biosolutions is a life sciences R&D enabling company with three focus areas, BioIT, Microarrays and Research services. The Microarray division of Ocimum has been recently acquired from MWG Biot...
Pantec Biosolutions specializes in precise skin microporation technology. Our proprietary P.L.E.A.S.E.® (Precise Laser EpidermAl SystEm) technology has been developed for:
Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the bodyâ...
More Information about "Ocimum Biosolutions Ltd." on BioPortfolio
We have published hundreds of Ocimum Biosolutions Ltd. news stories on BioPortfolio along with dozens of Ocimum Biosolutions Ltd. Clinical Trials and PubMed Articles about Ocimum Biosolutions Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ocimum Biosolutions Ltd. Companies in our database. You can also find out about relevant Ocimum Biosolutions Ltd. Drugs and Medications on this site too.
